U.S. Covid public health emergency ends, leaving behind a battered health system
Experts agree the U.S. has many more tools to fight Covid today, but warn the virus will remain a persistent threat to the nation’s battered health-care system.
Fed Governor Waller casts doubt on need to conduct climate change tests for banks
Waller on Thursday said that conducting special tests for how banks are preparing for such risks probably shouldn’t fall under the Fed’s purview.
U.S. holds ‘candid’ talks with China amid Russia’s war in Ukraine
U.S. officials aim to deter China from providing weapons or other support for Russia during its war in Ukraine.
Job growth cools for college grads, but ‘there’s still a lot of opportunity,’ career expert says
Although the overall outlook is positive, some industries are starting to cut back on new college graduate hires.
Wholesale prices rose just 0.2% in April, less than estimate as inflation pressures ease
Wholesale prices rose less than expected in April, according to a Labor Department report Thursday.
JPMorgan upgrades Taser maker: ‘Pullback we were waiting for came sooner than expected’
The Wall Street bank said the risk-reward is ‘more favorable at these levels today’ after Axon’s latest earnings results.
FAANG stocks could soar up to 50% this year, says Fundstrat’s Tom Lee
Tom Lee said on CNBC’s “Closing Bell” that tech shares could build up even further from an already successful year.
Trump pushes false election claims, mocks E. Jean Carroll to applause during CNN town hall
The town hall comes one day after a jury found Donald Trump liable for sexual abuse and defamation in a civil case brought by writer E. Jean Carroll.
Palantir dumps $50 million gold investment less than two years after buying precious metal
After buying $50 million worth of gold bars in 2021, the company said in its quarterly filing on Tuesday that it sold that investment for a minor gain.
FDA advisors recommend sale of birth control pill without a prescription
FDA scientists raised concerns about whether the general public will understand the drug label and use HRA Pharma’s Opill in the right way.
